| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9111993 | Diabetes Research and Clinical Practice | 2005 | 5 Pages |
Abstract
Blood glucose reduction instead of exogenous insulin is responsible for the C-peptide decrease during insulin therapy in type 2 diabetic subjects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
M. Albareda, M. Rigla, J. RodrÃguez-Espinosa, A. Caballero, A. Chico, R. Cabezas, G. Carreras, A. Pérez,